妊娠期vortioxetine暴露通过调节大鼠BDNF/Bax-Bcl2/5-HT通路损害妊娠结局和胎儿脑发育。

IF 6.9 2区 医学 Q1 TOXICOLOGY
Pallavi Singh, Priyanka Agrawal, K. P. Singh
{"title":"妊娠期vortioxetine暴露通过调节大鼠BDNF/Bax-Bcl2/5-HT通路损害妊娠结局和胎儿脑发育。","authors":"Pallavi Singh,&nbsp;Priyanka Agrawal,&nbsp;K. P. Singh","doi":"10.1007/s00204-025-04122-z","DOIUrl":null,"url":null,"abstract":"<div><p>Pregnancy presents a critical period during which the use of antidepressants requires cautious evaluation, especially due to the high incidence of depression in women of reproductive age. Vortioxetine hydrobromide (VOX), a newer multimodal antidepressant, is increasingly favored for its improved efficacy and tolerability. However, its safety profile during gestation and its potential long-term impact on fetal brain development remain insufficiently explored. This study aimed to assess the reproductive and developmental neurotoxicity of VOX administered at clinically relevant doses during pregnancy using a Wistar rat model. Pregnant dams received daily oral doses of either 1 mg/kg or 2 mg/kg of VOX from gestation day (GD) 6 to 21. On GD 21, the dams were euthanized, and fetuses along with placental tissues were collected for further analysis. Fetal brains underwent morphological, neurochemical, and histopathological evaluations. Exposure to VOX at the higher dose led to significant maternal and fetal toxicity, marked by reduced maternal weight gain, smaller litter sizes, and decreased fetal and placental weights. Notably, adverse neurodevelopmental outcomes were observed, including reduced fetal brain dimensions, cortical and hippocampal thinning, altered levels of brain-derived neurotrophic factor (BDNF), disrupted monoaminergic neurotransmitter levels (serotonin, dopamine, and norepinephrine), elevated apoptotic markers (Bax/Bcl-2 ratio), and increased acetylcholinesterase activity. These findings suggest that prenatal VOX exposure disrupts essential neurodevelopmental pathways, particularly those involving BDNF and monoaminergic signaling, potentially leading to persistent alterations in brain development. This is the first study to systematically demonstrate the developmental neurotoxicity of VOX, emphasizing the urgent need for further investigation into its safety during pregnancy.</p></div>","PeriodicalId":8329,"journal":{"name":"Archives of Toxicology","volume":"99 10","pages":"4243 - 4261"},"PeriodicalIF":6.9000,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gestational vortioxetine exposure impairs pregnancy outcomes and fetal brain development via modulation of BDNF/Bax-Bcl2/5-HT pathways in rats\",\"authors\":\"Pallavi Singh,&nbsp;Priyanka Agrawal,&nbsp;K. P. Singh\",\"doi\":\"10.1007/s00204-025-04122-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Pregnancy presents a critical period during which the use of antidepressants requires cautious evaluation, especially due to the high incidence of depression in women of reproductive age. Vortioxetine hydrobromide (VOX), a newer multimodal antidepressant, is increasingly favored for its improved efficacy and tolerability. However, its safety profile during gestation and its potential long-term impact on fetal brain development remain insufficiently explored. This study aimed to assess the reproductive and developmental neurotoxicity of VOX administered at clinically relevant doses during pregnancy using a Wistar rat model. Pregnant dams received daily oral doses of either 1 mg/kg or 2 mg/kg of VOX from gestation day (GD) 6 to 21. On GD 21, the dams were euthanized, and fetuses along with placental tissues were collected for further analysis. Fetal brains underwent morphological, neurochemical, and histopathological evaluations. Exposure to VOX at the higher dose led to significant maternal and fetal toxicity, marked by reduced maternal weight gain, smaller litter sizes, and decreased fetal and placental weights. Notably, adverse neurodevelopmental outcomes were observed, including reduced fetal brain dimensions, cortical and hippocampal thinning, altered levels of brain-derived neurotrophic factor (BDNF), disrupted monoaminergic neurotransmitter levels (serotonin, dopamine, and norepinephrine), elevated apoptotic markers (Bax/Bcl-2 ratio), and increased acetylcholinesterase activity. These findings suggest that prenatal VOX exposure disrupts essential neurodevelopmental pathways, particularly those involving BDNF and monoaminergic signaling, potentially leading to persistent alterations in brain development. This is the first study to systematically demonstrate the developmental neurotoxicity of VOX, emphasizing the urgent need for further investigation into its safety during pregnancy.</p></div>\",\"PeriodicalId\":8329,\"journal\":{\"name\":\"Archives of Toxicology\",\"volume\":\"99 10\",\"pages\":\"4243 - 4261\"},\"PeriodicalIF\":6.9000,\"publicationDate\":\"2025-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00204-025-04122-z\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"TOXICOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Toxicology","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00204-025-04122-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

怀孕是一个关键时期,在此期间需要谨慎评估抗抑郁药的使用,特别是由于育龄妇女抑郁症的高发。沃替西汀氢溴化物(VOX)是一种新型的多模式抗抑郁药,因其改善的疗效和耐受性而越来越受到青睐。然而,其在妊娠期间的安全性及其对胎儿大脑发育的潜在长期影响仍未得到充分探讨。本研究旨在利用Wistar大鼠模型,评估妊娠期间以临床相关剂量给予VOX的生殖和发育神经毒性。从妊娠第6天至第21天,妊娠母鼠每天口服1 mg/kg或2 mg/kg的VOX剂量。在妊娠第21天,对母鼠实施安乐死,收集胎儿及胎盘组织作进一步分析。对胎儿大脑进行形态学、神经化学和组织病理学评估。暴露于高剂量的VOX会导致显著的母体和胎儿毒性,其特征是母体体重增加减少,产仔数减少,胎儿和胎盘重量减少。值得注意的是,观察到不良的神经发育结果,包括胎儿脑尺寸缩小,皮质和海马变薄,脑源性神经营养因子(BDNF)水平改变,单胺能神经递质水平(血清素,多巴胺和去甲肾上腺素)中断,凋亡标志物(Bax/Bcl-2比率)升高,乙酰胆碱酯酶活性增加。这些发现表明,产前暴露于VOX会破坏基本的神经发育途径,特别是那些涉及BDNF和单胺能信号的途径,可能导致大脑发育的持续改变。这是第一个系统地证明VOX的发育神经毒性的研究,强调迫切需要进一步研究其在妊娠期间的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Gestational vortioxetine exposure impairs pregnancy outcomes and fetal brain development via modulation of BDNF/Bax-Bcl2/5-HT pathways in rats

Pregnancy presents a critical period during which the use of antidepressants requires cautious evaluation, especially due to the high incidence of depression in women of reproductive age. Vortioxetine hydrobromide (VOX), a newer multimodal antidepressant, is increasingly favored for its improved efficacy and tolerability. However, its safety profile during gestation and its potential long-term impact on fetal brain development remain insufficiently explored. This study aimed to assess the reproductive and developmental neurotoxicity of VOX administered at clinically relevant doses during pregnancy using a Wistar rat model. Pregnant dams received daily oral doses of either 1 mg/kg or 2 mg/kg of VOX from gestation day (GD) 6 to 21. On GD 21, the dams were euthanized, and fetuses along with placental tissues were collected for further analysis. Fetal brains underwent morphological, neurochemical, and histopathological evaluations. Exposure to VOX at the higher dose led to significant maternal and fetal toxicity, marked by reduced maternal weight gain, smaller litter sizes, and decreased fetal and placental weights. Notably, adverse neurodevelopmental outcomes were observed, including reduced fetal brain dimensions, cortical and hippocampal thinning, altered levels of brain-derived neurotrophic factor (BDNF), disrupted monoaminergic neurotransmitter levels (serotonin, dopamine, and norepinephrine), elevated apoptotic markers (Bax/Bcl-2 ratio), and increased acetylcholinesterase activity. These findings suggest that prenatal VOX exposure disrupts essential neurodevelopmental pathways, particularly those involving BDNF and monoaminergic signaling, potentially leading to persistent alterations in brain development. This is the first study to systematically demonstrate the developmental neurotoxicity of VOX, emphasizing the urgent need for further investigation into its safety during pregnancy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archives of Toxicology
Archives of Toxicology 医学-毒理学
CiteScore
11.60
自引率
4.90%
发文量
218
审稿时长
1.5 months
期刊介绍: Archives of Toxicology provides up-to-date information on the latest advances in toxicology. The journal places particular emphasis on studies relating to defined effects of chemicals and mechanisms of toxicity, including toxic activities at the molecular level, in humans and experimental animals. Coverage includes new insights into analysis and toxicokinetics and into forensic toxicology. Review articles of general interest to toxicologists are an additional important feature of the journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信